Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

Cancer Cell

Volumn 20, Issue 2, 2011, Pages 143-157

  Witt, Hendrik ^a,b   Mack, Stephen C ^c,d   Ryzhova, Marina ^e   Bender, Sebastian ^a,b   Sill, Martin ^a   Isserlin, Ruth ^d   Benner, Axel ^a   Hielscher, Thomas ^a   Milde, Till ^a,b   Remke, Marc ^a,b   Jones, David T W ^a   Northcott, Paul A ^c,d   Garzia, Livia ^c   Bertrand, Kelsey C ^c,d   Wittmann, Andrea ^a   Yao, Yuan ^c,d   Roberts, Stephen S ^f   Massimi, Luca ^g   Van Meter, Tim ^h   Weiss, William A ⁱ   Gupta, Nalin ^j   Grajkowska, Wiesia ^k   Lach, Boleslaw ^l   Cho, Yoon Jae ^m   von Deimling, Andreas ^a,n   Kulozik, Andreas E ^b   Witt, Olaf ^a,b   Bader, Gary D ^d   Hawkins, Cynthia E ^c,d   Tabori, Uri ^c,d   Guha, Abhijit ^c   Rutka, James T ^c,d   Lichter, Peter ^a   Korshunov, Andrey ^a,n   Taylor, Michael D ^c,d   Pfister, Stefan M ^a,b   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g CATHOLIC UNIVERSITY   (Italy)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF WARSAW   (Poland)

^l MCMASTER UNIVERSITY   (Canada)

^m BOSTON CHILDREN S HOSPITAL   (United States)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; EPENDYMOMA; FEMALE; GENE EXPRESSION PROFILING; GENOME ANALYSIS; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; POSTERIOR CRANIAL FOSSA TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TISSUE MICROARRAY; TUMOR CLASSIFICATION; TUMOR RECURRENCE; VALIDITY;

EID: 80051580421     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.07.007     Document Type: Article

References (38)

1. Birkbak N.J., Eklund A.C., Li Q., McClelland S.E., Endesfelder D., Tan P., Tan I.B., Richardson A.L., Szallasi Z., Swanton C. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res. 2011, 71:3447-3452.
2. Bouffet E., Perilongo G., Canete A., Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med. Pediatr. Oncol. 1998, 30:319-329. discussion 329-331.
3. Brunet J.P., Tamayo P., Golub T.R., Mesirov J.P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. USA 2004, 101:4164-4169.
4. Carter M., Nicholson J., Ross F., Crolla J., Allibone R., Balaji V., Perry R., Walker D., Gilbertson R., Ellison D.W. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br. J. Cancer 2002, 86:929-939.
5. Dyer S., Prebble E., Davison V., Davies P., Ramani P., Ellison D., Grundy R. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am. J. Pathol. 2002, 161:2133-2141.
6. Ebert C., von Haken M., Meyer-Puttlitz B., Wiestler O.D., Reifenberger G., Pietsch T., von Deimling A. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am. J. Pathol. 1999, 155:627-632.
7. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
8. Gibson P., Tong Y., Robinson G., Thompson M.C., Currle D.S., Eden C., Kranenburg T.A., Hogg T., Poppleton H., Martin J., et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095-1099.
9. Gilbertson, R.J., Bentley, L., Hernan, R., Junttila, T.T., Frank, A.J., Haapasalo, H., Connelly, M., Wetmore, C., Curran, T., Elenius, K., and Ellison, D.W. (2002). ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
10. Goeman J.J., van de Geer S.A., de Kort F., van Houwelingen H.C. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004, 20:93-99.
11. Grill J., Le Deley M.C., Gambarelli D., Raquin M.A., Couanet D., Pierre-Kahn A., Habrand J.L., Doz F., Frappaz D., Gentet J.C., et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J. Clin. Oncol. 2001, 19:1288-1296. French Society of Pediatric Oncology.
12. Hoshida Y., Brunet J.P., Tamayo P., Golub T.R., Mesirov J.P. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2007, 2:e1195.
13. Huber W., von Heydebreck A., Sültmann H., Poustka A., Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002, 18(Suppl 1):S96-S104.
14. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
15. Kilday J.P., Rahman R., Dyer S., Ridley L., Lowe J., Coyle B., Grundy R. Pediatric ependymoma: biological perspectives. Mol. Cancer Res. 2009, 7:765-786.
16. Korshunov A., Golanov A., Timirgaz V. Immunohistochemical markers for prognosis of ependymal neoplasms. J. Neurooncol. 2002, 58:255-270.
17. Korshunov A., Witt H., Hielscher T., Benner A., Remke M., Ryzhova M., Milde T., Bender S., Wittmann A., Schöttler A., et al. Molecular staging of intracranial ependymoma in children and adults. J. Clin. Oncol. 2010, 28:3182-3190.
18. Liu Y., Hayes D.N., Nobel A., Marron J. Statistical significance of clustering for high-dimension low sample size data. J. Am. Stat. Assoc. 2008, 103:1281-1293.
19. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109.
20. Mendrzyk F., Korshunov A., Benner A., Toedt G., Pfister S., Radlwimmer B., Lichter P. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin. Cancer Res. 2006, 12:2070-2079.
21. Merchant T.E., Mulhern R.K., Krasin M.J., Kun L.E., Williams T., Li C., Xiong X., Khan R.B., Lustig R.H., Boop F.A., Sanford R.A. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J. Clin. Oncol. 2004, 22:3156-3162.
22. Merchant T.E., Li C., Xiong X., Kun L.E., Boop F.A., Sanford R.A. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009, 10:258-266.
23. Merico D., Isserlin R., Stueker O., Emili A., Bader G.D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 2010, 5:e13984.
24. Monti S., Tamayo P., Mesirov J., Golub T.R. Consensus Clustering: a resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 2003, 52:91-118.
25. Preusser M., Wolfsberger S., Haberler C., Breitschopf H., Czech T., Slavc I., Harris A.L., Acker T., Budka H., Hainfellner J.A. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol. 2005, 109:211-216.
26. Puget S., Grill J., Valent A., Bieche I., Dantas-Barbosa C., Kauffmann A., Dessen P., Lacroix L., Geoerger B., Job B., et al. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J. Clin. Oncol. 2009, 27:1884-1892.
27. Rand V., Prebble E., Ridley L., Howard M., Wei W., Brundler M.A., Fee B.E., Riggins G.J., Coyle B., Grundy R.G. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. Br. J. Cancer 2008, 99:1136-1143. Children's Cancer and Leukaemia Group Biological Studies Committee.
28. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., Mesirov J.P. GenePattern 2.0. Nat. Genet. 2006, 38:500-501.
29. Rink J.C., Gurley K.A., Elliott S.A., Sánchez Alvarado A. Planarian Hh signaling regulates regeneration polarity and links Hh pathway evolution to cilia. Science 2009, 326:1406-1410.
30. Rousseeuw P.J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 1987, 20:53-65.
31. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Döhner H., Cremer T., Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997, 20:399-407.
32. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
33. Taylor M.D., Poppleton H., Fuller C., Su X., Liu Y., Jensen P., Magdaleno S., Dalton J., Calabrese C., Board J., et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323-335.
34. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. Cancer Genome Atlas Research Network.
35. Wilkerson M.D., Hayes D.N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 2010, 26:1572-1573.
36. Wilson C.W., Nguyen C.T., Chen M.H., Yang J.H., Gacayan R., Huang J., Chen J.N., Chuang P.T. Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis. Nature 2009, 459:98-102.
37. Zacharoulis S., Levy A., Chi S.N., Gardner S., Rosenblum M., Miller D.C., Dunkel I., Diez B., Sposto R., Ji L., et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr. Blood Cancer 2007, 49:34-40.
38. Zielinski B., Gratias S., Toedt G., Mendrzyk F., Stange D.E., Radlwimmer B., Lohmann D.R., Lichter P. Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 2005, 43:294-301.